coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Lancaster PCN, Lancaster · Health Inequalities Profile

    PCN U19808 · NHS Lancashire and South Cumbria Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    78,539

    Registered population

    68.4% aged 18–64

    16.0%

    Aged 65+

    ICB 20.0% · England 17.9%

    9.7%

    Ethnic minority (non-White)

    6.0% Asian · England 9.6%

    15.6%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~11,451

    Core20 residents (est.)

    Resident basis; registered basis ~8,739 · see page 3

    9,804

    Hypertension register

    +9.98% in 3 yrs · England +5.60%

    856

    SMI register

    48.3% of Lancaster's

    1,483

    COPD register

    Reviews -5.95% in 3 yrs

    Forecast to 2030

    11,837

    Hypertension patients, 2030

    +2,033 on today

    70.0%

    QRISK ≥20% on statins, 2030

    +2.67pp over 3 yrs

    4.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -9.6%
    Annual chronic disease reviews fell against England.

    From 2023 to 2025, heart failure reviews changed by -9.6% (England +8.7%), COPD by -6.0% (England +2.8%), and 64.7% asthma coverage leaves about 1,700.

    57.6%
    Cervical screening and pre-school MMR2 uptake lag.

    Cervical screening aged 25-49 is 57.6% (England 66.8%), while age-5 MMR coverage drops 7.5 pp from dose 1 (95.5%) to dose 2 (88.0%).

    +8.8%
    Register identification and diabetes HbA1c control grew.

    From 2023 to 2025, non-frail diabetes HbA1c control rose +8.8% (England +4.4%), alongside register growth for learning disability (+19.1%), hypertension (+10.0%) and BP recording.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Lancaster PCN's working-age share reaches 68.4%, exceeding borough, ICB and England benchmarks

    Across 78,539 registered patients, 68.4% are aged 18-64, higher than Lancaster (61.2%), the ICB (60.4%) and England (62.7%), while 16.0% are aged 65+ (Lancaster 21.8%, ICB 20.0%, England 17.9%). Lancaster Medical Practice has 70.4% aged 18-64 and 14.6% aged 65+, whereas Queen Square Medical Practice has 60.4% aged 18-64 and 21.8% aged 65+. In Census resident data, White residents represent 90.3% (Lancaster 93.1%, ICB 87.8%, England 81.1%) and Asian residents 6.0% (Lancaster 3.6%, ICB 9.4%, England 9.6%), framing working-age service planning. Projected list growth to 2030 is +0.7% (Lancaster +0.5%, ICB +1.7%, England +2.3%) via an unverified model.

    Age profile

    0–1715.6%
    18–6468.4%
    65+16.0%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White90.3%
    Asian6.0%
    Mixed1.8%
    Other0.9%
    Black0.9%

    Older people · falls rows are Lancaster local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Lancaster LA)1,8402,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Lancaster LA)9071,0219552024/25
    Falls deaths, all ages, per 100,000 (Lancaster LA)10.418.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 prevalence is 15.6%, with 7,166 estimated patients at Lancaster Medical Practice

    Lancaster PCN's Core20 share is 15.6%, below Lancaster (21.5%), the ICB (30.6%) and England (21.0%), alongside an average IMD decile of 6.2. However, the weighted practice Core20 share is 11.1%, and resident deciles 1 to 2 counts (11,451) diverge from registered practice estimates (8,739). Deprivation volume sits heavily in Lancaster Medical Practice (11.3% share; 7,166 estimated patients), compared with Queen Square Medical Practice (10.3%; 1,573 estimated patients). Reconciling resident and registered lists is required before deploying targeted outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Lancaster Medical11.3% · 7,166 patients
    Queen Square10.3% · 1,573 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    856

    SMI register

    1.05% recorded prevalence

    325

    Learning disability register

    0.40% recorded prevalence

    22

    Care homes, 661 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Lancaster, Census 2021

    The PCN records 856 patients on the severe mental illness register (1.1%, Lancaster 1.1%, ICB 1.2%, England 1.0%) and 325 on the learning disability register (0.4%, Lancaster 0.5%, ICB 0.6%, England 0.6%), alongside 22 catchment care homes with 661 beds.

    Severe mental illness: physical health checks

    In SMI physical health checks, 80.6% received blood pressure checks (England 83.4%) and 76.8% BMI checks (England 82.1%). Over 2023 to 2025, blood pressure checks rose +1.4 pp (England +4.4 pp) and BMI checks rose +2.9 pp (England +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,804

    Hypertension register

    +9.98%

    Register growth, 3 yrs

    Lancaster +8.94% · England +5.60%

    +3.66pp

    BP control, under 80

    ≤140/90 · +0.67pp aged 80+

    +2,033

    More patients by 2030

    Forecast 11,837 (14.56%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 12.0% across 9,804 registered patients, below Lancaster (15.5%), England (15.2%) and NHS Lancashire and South Cumbria Integrated Care Board (17.2%). Over 2023 to 2025, prevalence rose +10.0% (England +5.6%). Recent blood pressure checks reached 87.3% (England 90.0%, Lancaster 86.8%), and patients treated to target reached 68.0% (England 70.3%, Lancaster 65.2%). For patients aged under 80, control to <= 140/90 mmHg is 65.0% (England 67.8%). Across practices, prevalence is 11.5% at Lancaster Medical Practice and 14.3% at Queen Square Medical Practice. Lower recorded prevalence and treatment-to-target rates than England highlight operational scope to tighten blood pressure control through structured recall audits.

    Lipids and statins

    Lipid-lowering therapy reaches 64.2% of patients with QRISK ≥ 20% (England 63.6%, ICB 61.4%) and 73.4% in CKD (England 70.3%). However, statin treatment for diabetes without CVD fell 5.5% over 2023 to 2025 to 68.1% (England +2.1%, reaching 73.2%). Trailing national statin prescribing in diabetes may indicate missed primary prevention, making targeted diabetic medication review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026113,725£1.70£1.64£1.86£193,332
    Cardiovascular (all), 2025156,374£3.53£3.38£3.33£552,000

    Lipid-regulating drugs averaged £1.70 per item across 113,725 items (England £1.86, Lancaster £2.09, ICB £1.64). Across these items, the PCN spent £18,196 less than at England's unit cost, but £6,824 more than at the ICB unit cost. Unit costs sit below England, keeping expenditure lower while clinical review targets statin initiation.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.01%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.09%

    Asthma prevalence, PCN 3-yr % change

    While the COPD register rose +6.7% over 2023 to 2025 (to 1,483 patients, 1.8%) and asthma rose +3.1% (to 4,809 patients, 6.2%), annual reviews slipped. COPD 12-month reviews fell 6.0% to 75.0% (England +2.8%, 76.4%), and asthma reviews changed -0.01% to 64.7% (England +4.4%), leaving about 1,700 patients unreviewed. Furthermore, asthma management prescribing among ages 5-19 reached 1,784 per 1,000 (England 1,488). Expanding registers alongside falling reviews and elevated youth prescribing may reflect strained clinical review capacity.

    Cancer register and children's immunisation

    Cancer prevalence stands at 3.2% across 2,587 registered patients (England 3.8%). In Q1 2025/26 childhood immunisations, age-5 4-in-1 booster coverage is 83.5% (below the 95% target by 11.5 pp across 133 children). Additionally, age-5 MMR coverage shows a 7.5 pp difference between dose one (95.5%) and dose two (88.0%, below the 95% target by 7 pp). This pattern is consistent with pre-school recall drop-off.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.2%

    England 91.0%

    6-in-1 complete primary course at 24 months92.5%

    England 92.2%

    MMR dose 1 at 24 months87.4%

    England 88.3%

    MMR dose 2 at age 588.0%

    England 82.8%

    4-in-1 pre-school booster at age 583.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2 across NHS Lancashire and South Cumbria ICB (England 55.3%, national ambition 75.0%), with known-stage completeness at 74.6% (8,863 of 11,883). Closing that ICB gap would require about 2,010 extra early-stage cases. Locally, cervical screening coverage in women aged 25-49 is 57.6% (England 66.8%), varying from 54.8% at Lancaster Medical Practice to 68.4% at Queen Square Medical Practice. Prioritising recall at the lowest-coverage practice offers the most direct local opportunity to support early detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For University Hospitals of Morecambe Bay NHS Foundation Trust in Jul 2026 (provisional), cancer 62-day referral to treatment was 72.4% against the 85.0% standard (England 71.2%, ICB 73.6%). The trust achieved 78.4% on the 28-day faster diagnosis standard against the 75.0% standard (England 79.3%, ICB 78.4%). Patients waiting 6+ weeks across all diagnostic tests stood at 10.4% in Jul 2026 (England 23.1%). These hospital provider metrics reflect wider system performance rather than PCN-level delivery. Shorter diagnostic waits provide supportive context for referral pathways despite system 62-day operational pressures.

    Pathways within standard (%)of Morecambe BayBlackpoolLancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)78.3971.3882.9078.3979.32
    31-day treatment (96%)95.2297.9689.4393.6292.50
    62-day referral to treatment (85%)72.3567.4875.0473.6271.16
    Diagnostic waits over 6 weeks (%)of Morecambe BayBlackpoolLancashireEngland
    MRI4.0421.802.4121.40
    CT13.7616.4914.979.92
    Echocardiography10.557.5713.8528.48
    Colonoscopy0.6013.080.0030.83
    Gastroscopy1.4512.470.0029.02
    All 15 DM01 tests10.4426.5426.6523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In Jun 2026 (provisional), Lancashire residents had 293,090 community care activities, 126,445 contacts, 47,320 patients with contact and 20,415 referrals; adults aged 65+ had 56.9% of contacts (72,000). The ICB recorded 533,345 activities and 193,720 contacts. These provisional wider-system figures are not PCN performance. Older adult community contacts highlight system interfaces for cancer and chronic care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    QOF achievement reaches 95.4% and 95.5%, but vaccination achievement varies by 15.2 pp

    In 2025/26, overall QOF achievement reached 95.5% at Lancaster Medical Practice and 95.4% at Queen Square Medical Practice (England 92.5%). Clinical-domain achievement was 100.0% at Lancaster Medical Practice and 97.8% at Queen Square Medical Practice (England 97.1%). Vaccination and immunisation achievement spanned 15.2 pp, from 60.5% at Lancaster Medical Practice to 75.8% at Queen Square Medical Practice (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Lancaster Medical12411.351.2%84.8%83.0%
    Queen Square11210.355.1%70.0%75.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLancasterAssetPCNLancaster
    Care homes (catchment)22 (661 beds)n/aSchools (catchment)62n/a
    Children's centres510Places of worship72117
    Libraries47Day centres (VCS)11
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a2
    Primary schools (LA maintained)3049Primary academies23
    Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory and heart failure recall

    Asthma review coverage is 64.7% of 4,809 patients (England 65.7%), leaving 1,697 (about 1,700) unreviewed; COPD reviews fell 6.0% to 75.0% and heart failure fell 9.6% to 77.7%. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    In Q1 2025/26 across 133 age-5 children, MMR drops 7.5 pp from dose 1 (95.5%) to dose 2 (88.0%, 7 pp below 95%), and 4-in-1 is 83.5% (11.5 pp below 95%). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Combined SMI and CVD prevention checks

    Across 856 SMI patients, BP checks are 80.6% (England 83.4%) and BMI 76.8% (England 82.1%); from 2023 to 2025, smoking cessation offers fell 7.6 pp and diabetic statins fell 5.5%. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Core20 register reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Coordinated SMI physical checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Systematic blood pressure recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory and heart failure recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Combined SMI and CVD prevention checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15